Arch Therapeutics (Arch Therapeutics) Days Inventory : 5,528.92 (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Arch Therapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Arch Therapeutics's Average Total Inventories for the three months ended in Mar. 2024 was $1.33 Mil. Arch Therapeutics's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.02 Mil. Hence, Arch Therapeutics's Days Inventory for the three months ended in Mar. 2024 was 5,528.92.

The historical rank and industry rank for Arch Therapeutics's Days Inventory or its related term are showing as below:

ARTH' s Days Inventory Range Over the Past 10 Years
Min: 5654.18 Med: 8805.63 Max: 13937.59
Current: 5654.18

During the past 13 years, Arch Therapeutics's highest Days Inventory was 13937.59. The lowest was 5654.18. And the median was 8805.63.

ARTH's Days Inventory is ranked worse than
98.01% of 654 companies
in the Biotechnology industry
Industry Median: 192.63 vs ARTH: 5654.18

Arch Therapeutics's Days Inventory declined from Mar. 2023 (6,757.30) to Mar. 2024 (5,528.92).

Inventory Turnover measures how fast the company turns over its inventory within a year. Arch Therapeutics's Inventory Turnover for the three months ended in Mar. 2024 was 0.02.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Arch Therapeutics's Inventory-to-Revenue for the three months ended in Mar. 2024 was 41.66.

Arch Therapeutics Days Inventory Historical Data

The historical data trend for Arch Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Therapeutics Days Inventory Chart

Arch Therapeutics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Days Inventory

Get a 7-Day Free Trial

13,937.59

8,805.63

6,504.49

Arch Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Inventory	Get a 7-Day Free Trial															6,757.30	7,059.20	5,224.06	5,134.71	5,528.92

Competitive Comparison of Arch Therapeutics's Days Inventory

For the Biotechnology subindustry, Arch Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Therapeutics's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Arch Therapeutics's Days Inventory falls into.

Arch Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Arch Therapeutics's Days Inventory for the fiscal year that ended in Sep. 2023 is calculated as

	Days Inventory (A: Sep. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Sep. 2022 )	+	Total Inventories (A: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (A: Sep. 2023 )	*	Days in Period
=	( (1.415	+	1.365)	/	2 )	/	0.078	*	365
=	1.39					/	0.078	*	365
=	6,504.49

Arch Therapeutics's Days Inventory for the quarter that ended in Mar. 2024 is calculated as:

	Days Inventory (Q: Mar. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2023 )	+	Total Inventories (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (1.336	+	1.33)	/	2 )	/	0.022	*	365 / 4
=	1.333					/	0.022	*	365 / 4
=	5,528.92

Arch Therapeutics (OTCPK:ARTH) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Arch Therapeutics's Inventory Turnover for the three months ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.022	/	1.333
	=	0.02

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Arch Therapeutics's Inventory to Revenue for the three months ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1.333	/	0.032
	=	41.66

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Arch Therapeutics Days Inventory Related Terms

Thank you for viewing the detailed overview of Arch Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Therapeutics (Arch Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Therapeutics Inc (OTCPK:ARTH) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

235 Walnut Street, Suite 6, Framingham, MA, USA, 01702

Website

https://www.archtherapeutics.com

Arch Therapeutics Inc is a development-stage biotechnology company. It focuses on developing products that manage surgery and interventional care faster and safer by using a novel approach to stop bleeding, control leaking, and provide other advantages during surgery and trauma care. The company's primary product candidate, collectively known as the AC5 Devices (AC5), is designed to achieve hemostasis in surgical procedures. The company operates its business operations in the United States.

Executives

Terrence W Norchi	director, officer: President & CEO	C/O ARCH THERAPEUTICS, INC., PO BOX 748, NATICK MA 01760
Michael S Abrams	officer: CFO and Treasurer	64 RAMSHEAD ROAD, RAYNHAM MA 02767
Laurence Hicks	director	C/O ARCH THERAPEUTICS, INC., 235 WALNUT STREET, SUITE 6, FRAMINGHAM MA 01702
Guy L. Fish	director	C/O ARCH THERAPEUTICS, INC., 235 WALNUT STREET, SUITE 6, FRAMINGHAM MA 01702
Dan Yrigoyen	officer: Vice President, Sales	C/O ARCH THERAPEUTICS, INC., 235 WALNUT STREET, SUITE 6, FRAMINGHAM MA 01702
James R Sulat	director
Punit Dhillon	director	5820 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Richard E Davis	officer: CFO & Treasurer
Avtar S Dhillon	director	C/O GENETRONICS INC, 11199 SORRENTO VALLEY ROAD, SAN DIEGO CA 92121
Arthur L Rosenthal	director	100 CYBERONICS BLVD., HOUSTON TX 77058
Alan Barber	officer: Chief Financial Officer	C/O ARCH THERAPEUTICS, INC., PO BOX 748, NATICK MA 01760
William M Cotter	officer: Chief Operating Officer	C/O CLOSURE MEDICAL CORP, 5250 GREEN DAIRY RD, RALEIGH NC 27616